TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $3,152,000 | 0.20% |
| Baker Brothers Advisors | 7,624,835 | $10,751,000 | 0.06% |
| ArrowMark Colorado Holdings LLC | 3,735,237 | $5,267,000 | 0.05% |
| Golden State Equity Partners | 22,133 | $31,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 256,395 | $362,000 | 0.01% |
| Qube Research & Technologies Ltd | 47,467 | $67,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,000 | $76,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,745 | $4,000 | 0.00% |
| Legal & General Group Plc | 1,074 | $2,000 | 0.00% |